Study of focused radiation for laryngeal cancer
Part of Cancer clinical trials.
This Phase 1 study tests a precise type of radiation treatment for people with certain stages of laryngeal (voice box) squamous cell cancer. The goal is to see how safe the treatment is and how well it may work in shrinking or controlling the cancer while aiming to preserve the larynx.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and have confirmed squamous cell cancer of the voice box (larynx).
- Have a specific cancer stage: T1N1 or T2–4a with N0–1 (your staging tests must match this).
- Be able to do daily activities at a level of 0 to 2 (ECOG/Zubrod scale).
- Be considered able to undergo partial laryngectomy (partial removal of the voice box), based on a surgeon checklist.
- No prior surgery removing the main tumor from the voice box (no resection of the primary disease).
- Not have had induction chemotherapy or prior radiation to the head and neck area.
- If you could become pregnant, use birth control and do not become pregnant during the study and for 90 days after; also agree to follow the study’s consent rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called pembrolizumab (Keytruda) can help people with advanced throat cancer avoid removal of the voice box. You may be eligible if you have a specific type of larynx or hypopharynx cancer that hasn't been treated with radiation or immunotherapy before.
This study tests a special dye/light method during surgery for laryngeal and hypopharyngeal squamous cell cancer. The goal is to see if it’s safe and practical to help surgeons find the tumor more clearly.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This study tests if a shorter course of radiation (hypofractionated) works as well as the standard longer course for people with early-stage cancer of the vocal cords. The goal is to find a treatment that is more convenient and has similar results.
This trial tests a new approach to treat throat cancer while trying to preserve your larynx (voice box). It combines chemotherapy drugs and an immunotherapy drug before surgery or radiation. The goal is to see if this can help you avoid needing to have your larynx removed.
This trial tests treatment approaches for people with cancers of the voice box (larynx) or lower throat (hypopharynx). It may help by finding which treatment strategy works best for different tumor locations and cancer stages.
Hear when a new Squamous Cell Carcinoma of the Larynx trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.